On October 13, 2022, Xenetic Biosciences, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.875 USD | -2.04% | +0.78% | +14.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.65% | 6.09M | |
+7.21% | 113B | |
+11.00% | 106B | |
+0.93% | 22.27B | |
-12.36% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-5.86% | 17.24B | |
+7.59% | 14.29B | |
+34.81% | 12.52B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. announced that it has received $0.488835 million in funding from CLS Therapeutics, LLC